Trending:

June 7, 2026, 01:51 PM - 6 min read
Beyond diabetes and obesity, GLP-1 drugs have now earned regulatory approval in several new areas. A trial of more than 17,000 people found semaglutide cut the risk of serious heart attacks and strokes by 20 per cent, even in people without diabetes.
Read more
May 4, 2026, 04:02 PM - 2 min read
“It’s really disheartening. There was a pendulum that swung that was so body acceptance, positivity [and] everybody be who they want to be,” she said.
Read more
April 21, 2026, 06:22 PM - 2 min read
A nationwide alert has been issued to track these fake injections, while investigations are underway to expose the entire network and identify all those involved.
Read more